Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.67 |
| ▸ | TYR | P14679 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.51 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4055779 | 0.90 | MAPT (0.81) | MAPTMEN1KMT2AALOX5TYR | |
| SCHEMBL278523 | 0.88 | MAPT (0.78) | MAPTMEN1KMT2AALOX5TYR | |
| SCHEMBL4056986 | 0.84 | MAPT (0.72) | MAPTMEN1KMT2AALOX5TYR | |
| SCHEMBL875812 | 0.81 | MEN1 (1.00) | MAPTMEN1KMT2AALOX5TYR | |
| SCHEMBL13788030 | 0.81 | MEN1 (0.68) | MAPTMEN1KMT2AALOX5TYR | |
| SCHEMBL29655583 | 0.80 | ALOX5 (1.00) | MAPTMEN1KMT2AALOX5TYR | |
| SCHEMBL29655585 | 0.80 | ALOX5 (1.00) | MAPTMEN1KMT2AALOX5TYR | |
| SCHEMBL68292 | 0.80 | ALOX5 (1.00) | MAPTMEN1KMT2AALOX5TYR | |
| SCHEMBL51397 | 0.79 | TYR (0.71) | MAPTMEN1KMT2AALOX5TYR | |
| SCHEMBL278524 | 0.78 | MAPT (0.68) | MAPTMEN1KMT2AALOX5TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2313026-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | Castle Beach, L.L.C. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | Castle Beach, LLC (US) | 2010-02-18 | — | — | US | claimed |
| WO-2010019680-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | HOMOLA ANDREW M (US) | 2010-02-18 | — | — | WO | claimed |
| EP-0805672-B1 | METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH | HOMOLA ANDREW M (US) | 2004-08-25 | — | — | EP | claimed |
| US-5665333-A | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | PROVSEAL LLC | 1997-09-09 | — | — | US | claimed |
| US-20240041739-A1 | BIOPHOTONIC COMPOSITIONS AND METHODS FOR PROVIDING BIOPHOTONIC TREATMENT | KLOX TECHNOLOGIES INC. (CA) | 2024-02-08 | — | — | US | disclosed |
| US-11857653-B2 | Method of providing an oral care benefit using a poorly-soluble calcium compound and fluoride | JOHNSON & JOHNSON CONSUMER INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-11723854-B2 | Biophotonic compositions and methods for providing biophotonic treatment | FLE INTERNATIONAL S.R.L. (IT) | 2023-08-15 | — | — | US | disclosed |
| US-11648186-B2 | Coated particles and their uses | JOHNSON & JOHNSON CONSUMER INC. (US) | 2023-05-16 | — | — | US | disclosed |
| US-11590490-B2 | Pipette tips | BIOTIX, INC. (US) | 2023-02-28 | — | — | US | disclosed |
| CN-109843255-B | Ethanol-reducing mouthwash formulation | 强生消费者公司 | 2023-02-28 | — | — | CN | disclosed |
| US-20220387592-A1 | BIOPHOTONIC COMPOSITIONS AND METHODS FOR PROVIDING BIOPHOTONIC TREATMENT | FLE INTERNATIONAL S.R.L. (IT) | 2022-12-08 | — | — | US | disclosed |
| US-5192531-A | Triclosan as a water insoluble noncationic additive for dentifrices | COLGATE-PALMOLIVE COMPANY (US) | 1993-03-09 | — | — | US | disclosed |
| US-5192530-A | Solubilizer, enhancing agent to aid retention, and delivery enhancement | COLGATE-PALMOLIVE COMPANY (US) | 1993-03-09 | — | — | US | disclosed |
| US-5178851-A | Dentifrices treatment with triclosan and carriers | COLGATE-PALMOLIVE COMPANY (US) | 1993-01-12 | — | — | US | disclosed |
| WO-1992010992-A1 | ORAL COMPOSITIONS EFFECTIVE AGAINST PLAQUE AND GINGIVITIS | THE PROCTER & GAMBLE COMPANY (US) | 1992-07-09 | — | — | WO | disclosed |
| US-5080887-A | Polyphosphate, bactericide | COLGATE-PALMOLIVE COMPANY (US) | 1992-01-14 | — | — | US | disclosed |
| US-5037635-A | Antibacterial antiplaque oral composition | COLATE-PALMOLIVE COMPANY (US) | 1991-08-06 | — | — | US | disclosed |
| US-5032386-A | Dentistry | COLGATE-PALMOLIVE COMPANY (US) | 1991-07-16 | — | — | US | disclosed |
| US-4894220-A | WATER AND ALCOHOL SOLVENTS, GLYCOL DERIVATIVES AND ESTERS SOLUTIONS | COLGATE-PALMOLIVE COMPANY (US) | 1990-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | LIPA, MMP7, CTSA | MAPT 1445/4885MEN1 4098/4885KMT2A 4226/4885 |
| US-11648186-B2 | Coated particles and their uses | CD63, EPCAM, CD44 | MAPT 2500/4885MEN1 3074/4885KMT2A 2405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.